Results 161 to 170 of about 22,314 (175)

Marrow Microenvironmental Pathobiology and Therapeutic Opportunities for TP53-Mutated Myelodysplastic Syndrome/Acute Myeloid Leukemia. [PDF]

Cancers (Basel)
Hunter CJ, Im AP, Shallis RM.
europepmc   +1 more source

Efficacy of Venetoclax Combined with Azacitidine in Elderly Patients with Relapsed Acute Myeloid Leukemia. [PDF]

Mediterr J Hematol Infect Dis
Yan M, Wang G, Wang J, Xu L.
europepmc   +1 more source

Effective Management of Refractory Paraneoplastic Vasculitis in Myelodysplastic Syndromes With Azacitidine, Prednisolone, and Azathioprine. [PDF]

Case Rep Hematol
Takaba M, Nakano K, Yoda A, Otsuki Y, Fujisawa S.   +4 more
europepmc   +1 more source

Acute Myeloid Leukemia Secondary to Radiation Therapy for Rectal Cancer: A Case Report. [PDF]

Cancer Rep (Hoboken)
Alkhaledi A, Hussaen LA, Kahla L, Sammoud B, Ghanem SG.   +4 more
europepmc   +1 more source

Pivotal results of SELECT-MDS-1 phase 3 study of tamibarotene with azacitidine in newly diagnosed higher-risk MDS. [PDF]

Blood Adv
DeZern AE, Thepot S, de Botton S, Patriarca A, Deeren D, Torregrossa-Diaz JM, Marconi G, Bernal T, Bergua Burgues J, Xicoy B, Jonášová A, Zeidan AM, Dimicoli-Salazar S, Simand C, Valcarcel D, Diez Campelo M, Chai-Ho W, Saini L, Garnier A, Geissler K, Ofran Y, Nagy Z, Krishnamurthy P, Lübbert M, Basak G, Carraway HE, Sallman DA, Borate U, Santini V, Campbell V, Fenaux P, Braun T, Lanza F, Zaucha JM, Roth DA, Paul S, Roy P, Kelly MJ, Volkert A, Chisholm J, Malak TA, Klimek VM, Cluzeau T.   +42 more
europepmc   +1 more source

Reactivation of SNURF-SNRPN gene by DNA Methyltransferase inhibitors in a Prader-Willi lymphoblastoid cell line. [PDF]

, 2014
BAIAMONTE, Concetta
core  

Potential Off-Target Effect of Gilteritinib With Venetoclax Decreases Tumor Burden for Patients With Relapsed/Refractory Wild-Type <i>FLT3</i> Acute Myeloid Leukemia/Myelodysplastic Neoplasms. [PDF]

Case Rep Hematol
Chang S, Pan Z, Zhang Y, Zhang Y, Sun J, Guo Y, Guo X, Guo Z.   +7 more
europepmc   +1 more source

Real-world outcomes of azacitidine plus venetoclax in acute myeloid leukemia: a multicenter retrospective cohort study from Thailand. [PDF]

Ther Adv Hematol
Rattanathammethee T, Chanswangphuwana C, Silpsamrit P, Prayongratana K, Srichairatanakool S, Punnachet T, Hantrakun N, Piriyakhuntorn P, Hantrakool S, Chai-Adisaksopha C, Rattarittamrong E, Norasetthada L, Tantiworawit A.   +12 more
europepmc   +1 more source

Menin Inhibition in Acute Myeloid Leukemia: Pathobiology, Progress and Promise. [PDF]

Biomedicines
Joshi U, Shallis RM.
europepmc   +1 more source

Evolving Paradigms in Acute Myeloid Leukemia: Personalized Approaches to Therapy Across Age and Risk Groups. [PDF]

Cancers (Basel)
Yadav SK, Joshi U, Hussein G, Warsame M, Liu B, Shrestha A, Krastev P, Korsapati HR, Singh A.   +8 more
europepmc   +1 more source